Entry |
|
Name |
Oxacillin sodium (JAN/USP); Oxacillin sodium hydrate; Bactocill (TN) |
Product |
|
Generic |
OXACILLIN (Armas Pharmaceuticals), OXACILLIN (Eugia US LLC), OXACILLIN (Eugia US LLC), OXACILLIN (Fresenius Kabi USA), OXACILLIN (Fresenius Kabi USA), OXACILLIN (Sagent Pharmaceuticals), OXACILLIN (Sagent Pharmaceuticals), OXACILLIN (Sagent Pharmaceuticals), OXACILLIN (Sagent Pharmaceuticals), OXACILLIN (Wockhardt USA LLC.), OXACILLIN (Wockhardt USA LLC.) |
Formula |
C19H18N3O5S. Na. H2O
|
Exact mass |
441.0971
|
Mol weight |
441.4334
|
Structure |
|
Simcomp |
|
Class |
Antibacterial
DG01710 beta-Lactam antibiotic
DG01713 Penicillin skeleton group
DG01480 Penicillin
DG01779 beta-Lactamase resistant penicillin
|
Remark |
Product (DG00542): | D00929<US> |
|
Efficacy |
Antibacterial, Cell wall biosynthesis inhibitor |
Target |
penicillin binding protein |
Pathway |
|
Interaction |
|
Structure map |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS
J01CF Beta-lactamase resistant penicillins
J01CF04 Oxacillin
D00929 Oxacillin sodium (JAN/USP) <US>
USP drug classification [BR:br08302]
Antibacterials
Beta-lactam, Penicillins
Oxacillin
D00929 Oxacillin sodium (JAN/USP)
Drug groups [BR:br08330]
Antibacterial
DG01710 beta-Lactam antibiotic
DG01713 Penicillin skeleton group
DG01480 Penicillin
DG00542 Oxacillin
D00929 Oxacillin sodium
DG01779 beta-Lactamase resistant penicillin
DG00542 Oxacillin
D00929 Oxacillin sodium
Drug classes [BR:br08332]
Antibacterial
DG01480 Penicillin
D00929 Oxacillin sodium
Antimicrobials [BR:br08307]
Antibacterials
Cell wall biosynthesis inhibitor, beta-lactam
beta-Lactamase resistant penicillin
D00929 Oxacillin sodium (JAN/USP) <US>
Drug groups [BR:br08330]
Antibacterial
DG01710 beta-Lactam antibiotic
DG01713 Penicillin skeleton group
DG01480 Penicillin
DG00542 Oxacillin
DG01779 beta-Lactamase resistant penicillin
DG00542 Oxacillin
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Cell wall biosynthesis inhibitor, beta-lactam
beta-Lactamase resistant penicillin
DG00542 Oxacillin
|
Other DBs |
|
KCF data |
ATOM 30
1 C1y C 27.5667 -14.8899
2 C5x C 27.5667 -16.2792
3 N1y N 28.9560 -16.2792
4 C1y C 28.9560 -14.8899
5 C1y C 30.2759 -16.6960
6 C1z C 31.1096 -15.5845
7 S2x S 30.2759 -14.4731
8 C1a C 32.0821 -16.5571
9 C1a C 32.0821 -14.6120
10 C6a C 30.7622 -18.0854
11 O6a O 32.1515 -18.0854 #-
12 O6a O 29.9286 -19.1969
13 N1b N 26.3858 -14.1952
14 C5a C 25.2048 -14.8899
15 O5x O 26.3858 -16.9739
16 O5a O 25.2048 -16.2792
17 C8y C 23.9544 -14.1952
18 C8y C 23.9544 -12.8059
19 O2x O 22.6330 -12.3765
20 N5x N 21.8164 -13.5005
21 C8y C 22.6330 -14.6246
22 C1a C 25.0784 -11.9892
23 C8y C 22.6330 -16.0504
24 C8x C 21.3820 -16.7729
25 C8x C 21.3822 -18.1987
26 C8x C 22.6171 -18.9114
27 C8x C 23.8680 -18.1889
28 C8x C 23.8678 -16.7631
29 Z Na 33.7493 -18.1548 #+
30 O0 O 34.0271 -19.9610
BOND 31
1 1 2 1
2 2 3 1
3 3 4 1
4 1 4 1
5 3 5 1
6 5 6 1
7 6 7 1
8 4 7 1
9 6 8 1
10 6 9 1
11 5 10 1 #Down
12 10 11 1
13 10 12 2
14 1 13 1 #Up
15 13 14 1
16 2 15 2
17 14 16 2
18 14 17 1
19 17 18 2
20 18 19 1
21 19 20 1
22 20 21 2
23 17 21 1
24 18 22 1
25 21 23 1
26 23 24 2
27 24 25 1
28 25 26 2
29 26 27 1
30 27 28 2
31 23 28 1
|